Enhancing the Cellular Production of Extracellular Vesicles for Developing Therapeutic Applications
Pharmaceutical Research · 2023-04 · 40 (4) · 833-853
DOI: 10.1007/s11095-022-03420-w ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutical Research, online erschienen am 01.11.2022. Verfasst von Nina Erwin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, Florida, 32610, USA. Hauptthemen laut MEDLINE: Extracellular Vesicles. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences.
Abstract (Originalsprache)
Extracellular vesicles (EVs) have various advantageous properties, including a small size, high biocompatibility, efficient cargo loading, and precise cell targeting ability, making them promising tools for therapeutic development. EVs have been increasingly explored for applications like drug delivery. However, due to limited cellular secretion rates of EVs, wide-scale clinical applications are not achievable. Therefore, substantial strategies and research efforts have been devoted to increasing cellular secretion rates of EVs. This review describes various studies exploring different methods to increase the cellular production of EVs, including the application of electrical stimulus, pharmacologic agents, electromagnetic waves, sound waves, shear stress, cell starvation, alcohol, pH, heat, and genetic manipulation. These methods have shown success in increasing EV production, but careful consideration must be given as many of these strategies may alter EV properties and functionalities, and the exact mechanisms causing the increase in cellular production of EVs is generally unknown. Additionally, the methods' effectiveness in increasing EV secretion may diverge with different cell lines and conditions. Further advancements to enhance EV biogenesis secretion for therapeutic development is still a significant need in the field.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, Florida, 32610, USA.
- Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, Florida, 32610, USA. mhe@cop.ufl.edu.
- UF Cancer and Genetics Research Complex, 2033 Mowry Rd, Lab: 0475G, Gainesville, FL, 32608, USA. mhe@cop.ufl.edu.
Förderung
- NIGMS NIH HHS
- National Institute of General Medical Sciences
Zitieren
APA
Erwin, N., Serafim, M. F., & He, M. (2023). Enhancing the Cellular Production of Extracellular Vesicles for Developing Therapeutic Applications. Pharmaceutical Research, 40(4), 833-853. https://doi.org/10.1007/s11095-022-03420-w
Vancouver
Erwin N, Serafim MF, He M. Enhancing the Cellular Production of Extracellular Vesicles for Developing Therapeutic Applications. Pharmaceutical Research. 2023;40(4):833-853. doi:10.1007/s11095-022-03420-w
BibTeX
@article{Erwin2023,
author = {Erwin, Nina and Serafim, Maria Fernanda and He, Mei},
title = {Enhancing the Cellular Production of Extracellular Vesicles for Developing Therapeutic Applications},
journal = {Pharmaceutical Research},
year = {2023},
volume = {40},
number = {4},
pages = {833--853},
doi = {10.1007/s11095-022-03420-w}
}
EUVIMED